InsiderTradr

bioMérieux S.A. (0RUG.IL)

IOB · EUR · Healthcare · Diagnostics & Research

€89.35 (+0.37%) as of

Key statistics

Market cap
11.19B
P/E (TTM)
27.49
EPS (TTM)
3.25
Dividend yield
0.98%
52-week range
0.00 – 116.10
Beta
0.16
Revenue (TTM)
3.7B
Profit margin
10.43%
Volume
205.00

About bioMérieux S.A.

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Sector
Healthcare
Industry
Diagnostics & Research
Headquarters
Marcy l'Étoile, France
Employees
12,557

biomerieux.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks